Evidence map›Paper›PMID 41568456›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2026

Pathogenesis of Pulmonary Artery Remodeling: TGF-Beta Signaling and Inhibin Subunit Beta A in Group 1 and 2 Pulmonary Hypertension.

Yusuke Yamada, Taijyu Satoh, Nobuhiro Yaoita, Kaito Yamada, Naoki Chiba, Kohei Komaru, Kotaro Nochioka, Saori Yamamoto, Haruka Sato, Nobuhiro Kikuchi and 11 more

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yusuke YamadaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Taijyu SatohDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0002-1795-6872
Nobuhiro YaoitaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0003-2667-8031
Kaito YamadaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Naoki ChibaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0009-0000-8568-8382
Kohei KomaruDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0009-0005-8015-1849
Kotaro NochiokaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0001-8297-8624
Saori YamamotoDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Haruka SatoDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Nobuhiro KikuchiDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Takashi NakataDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Shinichiro SunamuraDepartment of Cardiology, Sendai City Medical Center, Sendai Open Hospital, Japan (S.S.).ORCID 0009-0007-7079-5071
Takumi InoueDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0009-0000-5405-1717
Hideka HayashiDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).
Hideaki SuzukiDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0002-0410-6940
Shunsuke TatebeDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0002-0245-2284
Hiroyuki TakahamaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0002-4868-0901
Hisashi OishiDepartment of Thoracic Surgery, Institute of Development, Aging and Cancer (H.O., Y.O.), Tohoku University, Sendai, Japan.ORCID 0000-0002-1381-6362
Satoshi MiyataTeikyo University Graduate School of Public Health, Tokyo, Japan (S.M.).ORCID 0000-0003-2400-7525
Yoshinori OkadaDepartment of Thoracic Surgery, Institute of Development, Aging and Cancer (H.O., Y.O.), Tohoku University, Sendai, Japan.ORCID 0000-0001-7739-7657
Satoshi YasudaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.Y., T.S., N.Y., K.Y., N.C., K.K., K.N., S. Yamamoto, H. Sato, N.K., T.N., T.I., H.H., H. Suzuki, S.T., H.T., S. Yasuda).ORCID 0000-0002-7470-5236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary hypertension (PH) due to left heart disease (group 2 PH) is associated with a worse prognosis than isolated heart failure. Both pulmonary arterial hypertension (group 1 PH) and group 2 PH are involved in pulmonary artery (PA) remodeling, which is potentially driven by shared molecular mechanisms. The aim of this study was to investigate the underlying processes contributing to PA remodeling in group 2 PH.

methodsTo mimic the response to a left-sided pressure load, pulmonary arterial smooth muscle cells (PASMCs) were subjected to mechanical stretch. RNA sequencing of PAs from patients with group 2 PH was performed using the Gene Expression Omnibus database. Mice with transverse aortic constriction and spontaneously hypertensive rats were used as group 2 PH models, and they were treated with adeno-associated virus via intratracheal instillation.

resultsRNA sequencing of PASMCs after the stretch stress identified 1585 genes specifically upregulated in PASMCs from patients with group 1 PH. Further PA and plasma analyses from patients with group 2 PH, integrated with group 1 PH findings, identified enhancement of TGF-β (transforming growth factor-beta) signaling by the INHBA (inhibin subunit beta A) as a key feature. Metabolomics revealed that stretch-induced mitochondrial dysfunction in PASMCs caused lactic acidosis via enhancement of PDK1 (pyruvate dehydrogenase kinase 1) and c-MYC, leading to increased INHBA expression. Mice with transverse aortic constriction exhibited increased INHBA expression, decreased PDH (pyruvate dehydrogenase) expression, and acidic alterations in PAs. Targeted silencing of INHBA or PDK1 using adeno-associated virus in mice with transverse aortic constriction attenuated PA remodeling, improved right ventricular function, and reduced PH.

conclusionsIntegrated RNA sequencing and metabolomics with stretched PASMCs and animal models identified mitochondrial dysfunction and subsequent acidic alterations as stimulators of increased INHBA expression and TGF-β signaling. These mechanisms contributed to PA remodeling in group 2 PH and provided potential therapeutic strategies.

Indexed as

heart failurehypertension, pulmonarypulmonary arterysmooth muscletransforming growth factors

Identifiers

PMID41568456
PMCPMC12931867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.